Endurant Capital Management LP Pfizer Inc Transaction History

Endurant Capital Management LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$26.13 - $33.94 $412,592 - $535,912	15,790 New	15,790 $454,000
Q1 2023 May 15, 2023	BUY	$39.39 - $51.28 $2.89 Million - $3.76 Million	73,265 New	73,265 $2.99 Million
Q2 2020 Aug 14, 2020	SELL	$30.12 - $36.54 $15.4 Million - $18.6 Million	-510,150 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$27.03 - $38.62 $13.8 Million - $19.7 Million	510,150 New	510,150 $16.7 Million
Q4 2018 Feb 14, 2019	SELL	$38.47 - $43.86 $3.55 Million - $4.05 Million	-92,390 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$34.47 - $41.81 $2.01 Million - $2.43 Million	58,238 Added 170.53%	92,390 $4.07 Million
Q2 2018 Aug 14, 2018	BUY	$32.98 - $35.16 $1.13 Million - $1.2 Million	34,152 New	34,152 $1.24 Million
Q4 2017 Feb 14, 2018	SELL	$33.26 - $35.29 $7.56 Million - $8.02 Million	-227,319 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$31.0 - $34.15 $7.05 Million - $7.76 Million	227,319	227,319 $8.12 Million

3,267

3.73B

74.2M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $147B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Endurant Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Endurant Capital Management LP with notifications on news.